Table 2. Follow-up Clinical Measures in UHR Participants.
| UHR-R N=22 | UHR-NR N=29 | P | |
|---|---|---|---|
| Thought content abnormalities | 0.2 (0.5) | 3.6 (1.9) | <0.001 |
| Perception abnormalities | 0.2 (0.5) | 3.6 (1.9) | <0.001 |
| Speech abnormalities | 0.7 (0.9) | 2.1 (1.8) | 0.001 |
| Total attenuated positive symptoms | 1.1 (1.3) | 9.3 (3.9) | <0.001 |
| GAF score | 72.5 (11.2) | 54.6 (15.8) | <0.001 |
| PANSS-P | 8.2 (1.7) | 14.9 (4.9) | <0.001 |
| PANSS-N | 8.3 (2.5) | 11.2 (5.0) | 0.02 |
| PANSS-G | 18.7 (3.7) | 25.5 (7.5) | 0.001 |
| PANSS-T | 35.2 (7.0) | 51.6 (15.8) | <0.001 |
Abbreviations: G, general; GAF, global assessment of functioning scale; N, negative; P, positive; PANSS, positive and negative syndrome scale, T, total symptom scores; UHR-R, ultra high risk - remission; UHR-NR, ultra high risk - non remission.